Astonea Labs Ltd — Important, 30-05-2026: Company Update

Astonea Labs has confirmed a change in its Initial Public Offering (IPO) fund utilization, previously approved by its Board and shareholders. The company reallocated Rs 6.25 crore from the initial IPO proceeds to strategically acquire an equity stake in Damaira Pharmaceuticals Private Limited. This move aims to leverage growth opportunities and strengthen long-term business synergies. As of March 31, 2026, Rs 35.91 crore of the Rs 37.67 crore raised through the IPO has been utilized, with Rs 1.75 crore remaining unutilized. This reflects prudent capital re-prioritization.